These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1908824)

  • 1. Effects of activated macrophages on Mycobacterium leprae.
    Ramasesh N; Adams LB; Franzblau SG; Krahenbuhl JL
    Infect Immun; 1991 Sep; 59(9):2864-9. PubMed ID: 1908824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical optima for metabolism of Mycobacterium leprae.
    Franzblau SG; Harris EB
    J Clin Microbiol; 1988 Jun; 26(6):1124-9. PubMed ID: 3290244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competency of human-derived Mycobacterium leprae to use palmitic acid in the synthesis of phenolic glycolipid-I and phthiocerol dimycocerosate and to release CO2 in axenic culture.
    Shannon EJ; Harris EB; Haile-Mariam HS; Guebre-Xavier M; Frommel D
    Lepr Rev; 1992 Jun; 63(2):101-7. PubMed ID: 1640777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of Mycobacterium leprae in macrophages.
    Ramasesh N; Hastings RC; Krahenbuhl JL
    Infect Immun; 1987 May; 55(5):1203-6. PubMed ID: 3552993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations into the growth of Mycobacterium leprae in a medium with palmitic acid under different gaseous environments.
    Ishaque M; Sticht-Groh V
    Microbios; 1993; 75(304):171-9. PubMed ID: 8246810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of radiometric macrophage assay and fluorescein diacetate/ethidium bromide staining for evaluation of M. leprae viability.
    Harshan KV; Prasad HK; Chopra NK; Mishra RS; Gogiya P; Nath I
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):316-21. PubMed ID: 2439621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of metabolism and growth of Mycobacterium leprae by gamma irradiation.
    Adams LB; Soileau NA; Battista JR; Krahenbuhl JL
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):1-10. PubMed ID: 10834063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titration of numbers of human-derived Mycobacterium leprae required to progressively oxidize 14C-palmitic acid and release 14CO2.
    Shannon EJ; Frommel D; Guebre-Xabier M; Haile-Mariam HS
    Lepr Rev; 1994 Jun; 65(2):100-5. PubMed ID: 7968182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.
    Desai SD; Birdi TJ; Antia NH
    Infect Immun; 1989 Apr; 57(4):1311-7. PubMed ID: 2494115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro model for the lepromatous leprosy granuloma: fate of Mycobacterium leprae from target macrophages after interaction with normal and activated effector macrophages.
    Hagge DA; Ray NA; Krahenbuhl JL; Adams LB
    J Immunol; 2004 Jun; 172(12):7771-9. PubMed ID: 15187161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of Intracellular Metabolites: An Approach to Understanding the Characteristic Physiology of Mycobacterium leprae.
    Miyamoto Y; Mukai T; Matsuoka M; Kai M; Maeda Y; Makino M
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004881. PubMed ID: 27479467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of phenolic glycolipid-I synthesis in extracellular Mycobacterium leprae as an indicator of antimicrobial activity.
    Harris EB; Franzblau SG; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):588-91. PubMed ID: 3065422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
    Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of potassium tellurite and ATP content in Mycobacterium leprae.
    David HL; Rastogi N; Frehel C; Gheorghiu M
    Ann Microbiol (Paris); 1982; 133(1):129-39. PubMed ID: 7051925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ultraviolet light radiation on Mycobacterium leprae.
    Truman RW; Gillis TP
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):11-7. PubMed ID: 10834064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial of sparfloxacin for lepromatous leprosy.
    Chan GP; Garcia-Ignacio BY; Chavez VE; Livelo JB; Jimenez CL; Parrilla ML; Franzblau SG
    Antimicrob Agents Chemother; 1994 Jan; 38(1):61-5. PubMed ID: 8141581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages.
    Ramasesh N; Krahenbuhl JL; Hastings RC
    Antimicrob Agents Chemother; 1989 May; 33(5):657-62. PubMed ID: 2665640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the viability of Mycobacterium leprae by the fluorescein diacetate/ethidium bromide staining technique.
    Palomino JC; Falconi E; Marin D; Guerra H
    Indian J Lepr; 1991; 63(2):203-8. PubMed ID: 1723741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of purification and fluorescent staining on viability of Mycobacterium leprae.
    Lahiri R; Randhawa B; Krahenbuhl JL
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):194-202. PubMed ID: 16830641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining.
    Katoch VM; Katoch K; Ramanathan U; Sharma VD; Shivannavar CT; Datta AK; Bharadwaj VP
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):615-21. PubMed ID: 2476522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.